396 related articles for article (PubMed ID: 35267561)
1. Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021.
Bou Zerdan M; Ghorayeb T; Saliba F; Allam S; Bou Zerdan M; Yaghi M; Bilani N; Jaafar R; Nahleh Z
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267561
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancer: advancements in characterization and treatment approach.
Hurvitz S; Mead M
Curr Opin Obstet Gynecol; 2016 Feb; 28(1):59-69. PubMed ID: 26694831
[TBL] [Abstract][Full Text] [Related]
3. Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches.
Nguyen HM; Paulishak W; Oladejo M; Wood L
Breast Cancer; 2023 Mar; 30(2):167-186. PubMed ID: 36399321
[TBL] [Abstract][Full Text] [Related]
4. [Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates].
Dalenc F; Sarradin V; Nicolaï V; Franchet C; Ung M
Bull Cancer; 2021 Jan; 108(1):67-79. PubMed ID: 33422340
[TBL] [Abstract][Full Text] [Related]
5. Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer.
Tong L; Yu X; Wang S; Chen L; Wu Y
Breast Cancer (Dove Med Press); 2023; 15():647-658. PubMed ID: 37644916
[TBL] [Abstract][Full Text] [Related]
6. Targeted Therapies for Triple-Negative Breast Cancer.
Lyons TG
Curr Treat Options Oncol; 2019 Nov; 20(11):82. PubMed ID: 31754897
[TBL] [Abstract][Full Text] [Related]
7. Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
Sakach E; O'Regan R; Meisel J; Li X
Clin Breast Cancer; 2021 Dec; 21(6):509-520. PubMed ID: 34629314
[TBL] [Abstract][Full Text] [Related]
8. Targeted Therapies in Triple-Negative Breast Cancer.
Marmé F; Schneeweiss A
Breast Care (Basel); 2015 Jul; 10(3):159-66. PubMed ID: 26557820
[TBL] [Abstract][Full Text] [Related]
9. Novel Agents for Metastatic Triple-Negative Breast Cancer: Finding the Positive in the Negative.
Vidula N; Ellisen LW; Bardia A
J Natl Compr Canc Netw; 2020 Oct; ():1-9. PubMed ID: 33075745
[TBL] [Abstract][Full Text] [Related]
10. Research advances and new challenges in overcoming triple-negative breast cancer.
Zong Y; Pegram M
Cancer Drug Resist; 2021; 4(3):517-542. PubMed ID: 34888495
[TBL] [Abstract][Full Text] [Related]
11. Current landscape of personalized clinical treatments for triple-negative breast cancer.
Zhang J; Xia Y; Zhou X; Yu H; Tan Y; Du Y; Zhang Q; Wu Y
Front Pharmacol; 2022; 13():977660. PubMed ID: 36188535
[TBL] [Abstract][Full Text] [Related]
12. The evolving management of metastatic triple negative breast cancer.
Malhotra MK; Emens LA
Semin Oncol; 2020 Aug; 47(4):229-237. PubMed ID: 32563561
[TBL] [Abstract][Full Text] [Related]
13. Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice.
Carlino F; Diana A; Piccolo A; Ventriglia A; Bruno V; De Santo I; Letizia O; De Vita F; Daniele B; Ciardiello F; Orditura M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565233
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancer: molecular subtypes and new targets for therapy.
Lehmann BD; Pietenpol JA; Tan AR
Am Soc Clin Oncol Educ Book; 2015; ():e31-9. PubMed ID: 25993190
[TBL] [Abstract][Full Text] [Related]
15. Advances in Targeted Therapies for Triple-Negative Breast Cancer.
McCann KE; Hurvitz SA; McAndrew N
Drugs; 2019 Jul; 79(11):1217-1230. PubMed ID: 31254268
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Treatment of Breast Cancer.
Tong CWS; Wu M; Cho WCS; To KKW
Front Oncol; 2018; 8():227. PubMed ID: 29963498
[TBL] [Abstract][Full Text] [Related]
17. Triple-negative breast cancer: A run-through of features, classification and current therapies.
Manjunath M; Choudhary B
Oncol Lett; 2021 Jul; 22(1):512. PubMed ID: 33986872
[TBL] [Abstract][Full Text] [Related]
18. Untangling Triple-Negative Breast Cancer Molecular Peculiarity and Chemo-Resistance: Trailing Towards Marker-Based Targeted Therapies.
Kanwal B
Cureus; 2021 Jul; 13(7):e16636. PubMed ID: 34458041
[TBL] [Abstract][Full Text] [Related]
19. Innovations in targeted therapies for triple negative breast cancer.
McCann KE; Hurvitz SA
Curr Opin Obstet Gynecol; 2021 Feb; 33(1):34-47. PubMed ID: 33093337
[TBL] [Abstract][Full Text] [Related]
20. Targeted Therapeutic Strategies for Triple-Negative Breast Cancer.
Li Y; Zhan Z; Yin X; Fu S; Deng X
Front Oncol; 2021; 11():731535. PubMed ID: 34778045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
